Offshore
Photo
Dimitry Nakhla | Babylon Capital®
This week’s reading material 📖
“Informed by successful, evolutionary strategies, Prasad outlines his counterintuitive principles for a long-term gain.
He provides three mantras of investing:
1. Avoid big risks;
2. Buy high-quality at a fair price;
3. And be very lazy.” https://t.co/zxVkLjgojl
tweet
This week’s reading material 📖
“Informed by successful, evolutionary strategies, Prasad outlines his counterintuitive principles for a long-term gain.
He provides three mantras of investing:
1. Avoid big risks;
2. Buy high-quality at a fair price;
3. And be very lazy.” https://t.co/zxVkLjgojl
tweet
InsideArbitrage
💊 $MRK Merck Boosts Buyback & Declares Q2 2025 Dividend!
🔹 Adds $10 Billion to its stock repurchase plan (4% of its $246.5B market cap) 📈
🔹 No expiration date, follows a similar 2018 $10 billion buyback boost
🔹 $2.9B still available under prior programs
🔹 2024: Repurchased $817 million (7 million shares) of its common stock under the prior program till September
🔹2023: $8.8B returned to shareholders ($7.4B dividends, $1.3B buybacks) – leaning more on dividends than repurchases💰
https://t.co/jbgkKGyk1U
tweet
💊 $MRK Merck Boosts Buyback & Declares Q2 2025 Dividend!
🔹 Adds $10 Billion to its stock repurchase plan (4% of its $246.5B market cap) 📈
🔹 No expiration date, follows a similar 2018 $10 billion buyback boost
🔹 $2.9B still available under prior programs
🔹 2024: Repurchased $817 million (7 million shares) of its common stock under the prior program till September
🔹2023: $8.8B returned to shareholders ($7.4B dividends, $1.3B buybacks) – leaning more on dividends than repurchases💰
https://t.co/jbgkKGyk1U
tweet
twitter.com
undefined
undefined
Offshore
Photo
Quiver Quantitative
Unless I'm missing something, it appears that Caroline Kennedy no longer holds significant amounts of stock in $BMY, $LLY, and $JNJ.
Here is a 2023 disclosure which appears to show divestiture. https://t.co/eoPLxwZtRr
tweet
Unless I'm missing something, it appears that Caroline Kennedy no longer holds significant amounts of stock in $BMY, $LLY, and $JNJ.
Here is a 2023 disclosure which appears to show divestiture. https://t.co/eoPLxwZtRr
Caroline Kennedy's 2023 financial disclosure shows that she holds a significant position in Bristol-Myers Squibb, Eli Lilly & Co, and Johnson & Johnson.
Perhaps the childhood stories from 50 years ago are just ugly smears to stop him from reforming U.S. healthcare?🤔 tweet
Offshore
Photo
InsideArbitrage
🚨 $SYK Stryker Glenn S. Boehnlein to retire as VP & CFO after 22 years.
- Preston Wells, current Group CFO for Orthopaedics, will step into the CFO role effective April 1, 2025.
💼 Preston Wells’ Background: Previously led Investor Relations & Financial Planning at Stryker. Prior experience includes finance leadership at Dialight Corp & Johnson & Johnson.
💰 Compensation Update: Wells’ base salary set at $725K, with an 85% bonus target (~$616K). A $3M stock award (60% PSUs, 40% options) is recommended under Stryker’s LTIP. Performance review scheduled for Feb 2026. 📈
🔄 Transition Plan: Boehnlein to serve as Advisor to CEO from April 2025 to March 2026, earning $800K salary + $215K advisory bonus if he remains through term.
tweet
🚨 $SYK Stryker Glenn S. Boehnlein to retire as VP & CFO after 22 years.
- Preston Wells, current Group CFO for Orthopaedics, will step into the CFO role effective April 1, 2025.
💼 Preston Wells’ Background: Previously led Investor Relations & Financial Planning at Stryker. Prior experience includes finance leadership at Dialight Corp & Johnson & Johnson.
💰 Compensation Update: Wells’ base salary set at $725K, with an 85% bonus target (~$616K). A $3M stock award (60% PSUs, 40% options) is recommended under Stryker’s LTIP. Performance review scheduled for Feb 2026. 📈
🔄 Transition Plan: Boehnlein to serve as Advisor to CEO from April 2025 to March 2026, earning $800K salary + $215K advisory bonus if he remains through term.
tweet
Offshore
Photo
InsideArbitrage
$CLX Clorox's long-time CFO, Kevin Jacobsen, will step down on April 1, 2025. He will remain in an advisory role until June 2025.
Luc Bellet, currently Vice President – Treasurer, will succeed Jacobsen as Executive Vice President – Chief Financial Officer, effective April 1, 2025.
Compensation
$725K base salary
Short-term incentive target raised from 50% to 100% of salary.
$400K in RSUs (4-year vesting)
$600K in performance shares (3-year period)
📢 Clorox set to report Q2 earnings next week!
tweet
$CLX Clorox's long-time CFO, Kevin Jacobsen, will step down on April 1, 2025. He will remain in an advisory role until June 2025.
Luc Bellet, currently Vice President – Treasurer, will succeed Jacobsen as Executive Vice President – Chief Financial Officer, effective April 1, 2025.
Compensation
$725K base salary
Short-term incentive target raised from 50% to 100% of salary.
$400K in RSUs (4-year vesting)
$600K in performance shares (3-year period)
📢 Clorox set to report Q2 earnings next week!
tweet
Offshore
Photo
InsideArbitrage
Medical technology company - $BDX Becton, Dickinson and Company Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; Completed $750 Million Repurchase to Date in FY25
https://t.co/37Z1MbfdN0
tweet
Medical technology company - $BDX Becton, Dickinson and Company Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; Completed $750 Million Repurchase to Date in FY25
https://t.co/37Z1MbfdN0
tweet
Offshore
Photo
Investing visuals
$ASML Q4 2024 Earnings 🚨
Beats across the board and absolutely smashed booking with €7.09B (Est. €3.53B)
Stock is up +7% pre-market https://t.co/OCNRRERUuw
tweet
$ASML Q4 2024 Earnings 🚨
Beats across the board and absolutely smashed booking with €7.09B (Est. €3.53B)
Stock is up +7% pre-market https://t.co/OCNRRERUuw
tweet
Offshore
Photo
InsideArbitrage
Zimmer Biomet $ZBH Acquires Paragon 28 $FNA for $1.2 Billion -
👣Zimmer Biomet will acquire all outstanding shares of common stock of Paragon 28 for an upfront payment of $13.00 per share in cash, representing a premium of 8.33% from the stock’s last close.
👣Paragon 28 shareholders will also receive a CVR of up to $1.00 per share in cash if Zimmer's net sales exceed $346 million up to $361 million during its fiscal year 2026.
👣Zimmer plans to fund the transaction with a mix of cash and debt financing and aims to close it in H1 2025.
tweet
Zimmer Biomet $ZBH Acquires Paragon 28 $FNA for $1.2 Billion -
👣Zimmer Biomet will acquire all outstanding shares of common stock of Paragon 28 for an upfront payment of $13.00 per share in cash, representing a premium of 8.33% from the stock’s last close.
👣Paragon 28 shareholders will also receive a CVR of up to $1.00 per share in cash if Zimmer's net sales exceed $346 million up to $361 million during its fiscal year 2026.
👣Zimmer plans to fund the transaction with a mix of cash and debt financing and aims to close it in H1 2025.
tweet
Offshore
Photo
App Economy Insights
$ASML ASML Q4 FY24:
• Net bookings €7.1B (€3.1B beat).
• Net sales +28% Y/Y to €9.3B (€0.2B beat).
• Gross margin 52% (flat Y/Y).
• Operating margin 36% (+3pp Y/Y).
• EPS €6.85 (€0.12 beat).
Q1 FY25 Net sales guidance:
• €7.5-8.0B (€7.2B expected). https://t.co/Sowyso6daH
tweet
$ASML ASML Q4 FY24:
• Net bookings €7.1B (€3.1B beat).
• Net sales +28% Y/Y to €9.3B (€0.2B beat).
• Gross margin 52% (flat Y/Y).
• Operating margin 36% (+3pp Y/Y).
• EPS €6.85 (€0.12 beat).
Q1 FY25 Net sales guidance:
• €7.5-8.0B (€7.2B expected). https://t.co/Sowyso6daH
tweet
Hidden Value Gems
Only 13% of people in this mini survey are worried about the DeepSeek threat to US tech. Quite a bullish sentiment.
tweet
Only 13% of people in this mini survey are worried about the DeepSeek threat to US tech. Quite a bullish sentiment.
What are your thoughts? 🤔👇
Is DeepSeek a game changer for US tech?
#DeepSeek #Stocks #NASDAQ #AI
- No
- Yes - lower capex (good)
- Don't know
- Yes- lower margins/growth tweet
twitter.com
undefined
undefined
Offshore
Photo
Stock Analysis Compilation
Fiduciary Management on Edenred SE $EDEN FP
Thesis: Edenred SE is a leading digital payment solutions platform, particularly known for its meal vouchers business, which generates strong returns despite current regulatory challenges, and is expected to achieve significant earnings growth.
(Extract from their Q4 letter)
tweet
Fiduciary Management on Edenred SE $EDEN FP
Thesis: Edenred SE is a leading digital payment solutions platform, particularly known for its meal vouchers business, which generates strong returns despite current regulatory challenges, and is expected to achieve significant earnings growth.
(Extract from their Q4 letter)
tweet